银杏蜜环口服溶液联合氟哌噻吨美利曲辛治疗缺血性脑卒中后抑郁的临床效果

Abstract
Figure/Table
References (19)
Related Citation (15)

Download: PDF (585 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the clinical efficacy of Ginkgo Armillaria Oral Solution combined with Flupentixol and Melitracen in the treatment of post ischemic stroke depression. Methods A total of 100 patients with mild to moderate post ischemic stroke depression admitted to the Department of Neurology in the Second Affiliated Hospital of Gannan Medical University from January 2019 to February 2020 were selected as subjects. They were divided into two groups with 50 cases in each group by random number parity method. The patients in the two groups were given routine treatment and necessary rehabilitation treatment. The control group was treated with Flupentixol and Melitracen on the basis of routine treatment, and the experimental group was treated with Flupentixol and Melitracen and Ginkgo Armillaria Oral Solution on the basis of routine treatment. The patients in the two groups were treated continuously for 4 weeks. Hamilton depression scale (HAMD) score and Barthel index (BI) were compared between the two groups before and after treatment.The clinical efficacy of the two groups was compared.The incidence of adverse reactions was compared between the two groups. Results The HAMD scores of the two groups after treatment were lower than those before treatment, BI scores of the two groups after treatment were higher than those before treatment, the differences were statistically significant (P<0.05). After treatment, HAMD score of experimental group was lower than that of control group, BI score was higher than that of control group, the differences were statistically significant (P<0.05). The total effective rate of experimental group (90.00%) was higher than that of control group (74.00%), and the difference was statistically significant (P＜0.05). There was no significant difference in the total incidence of adverse reactions between the two groups (P＞0.05). Conclusion The effect of Ginkgo Armillaria Oral Solution combined with Flupentixol and Melitracen in the treatment of post ischemic stroke depression is better than that of Flupentixol and Melitracen alone, and it can improve the patients′ ability of daily living and depression symptoms at 4 weeks.

Key words： Ginkgo Armillaria Oral Solution Flupentixol and Melitracen Post ischemic stroke depression Therapeutic effect

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2022/V29/I13/58

[1]	中华医学会神经病学分会，中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志，2018，51（9）：666-682.
[2]	Wang W，Jiang B，Sun H，et al.NESS-China Investigators.Prevalence，Incidence，and Mortality of Stroke in China：Results from a Nationwide Population-Based Survey of 480 687 Adults[J].Circulation，2017，135（8）：759-771.
[3]	Feigin VL，Norrving B，Mensah GA.Global Burden of Stroke[J].Circ Res，2017，120（3）：439-448.
[4]	Villa RF，Ferrari F，Moretti A.Post-stroke depression：Mechanisms and pharmacological treatment[J].Pharmacol Ther，2018，184：131-144.
[5]	中华医学会精神病学分会.中国精神障碍分类与诊断标准第三版（精神障碍分类）[J].中华精神科杂志，2001，34（3）：184-188.
[6]	中华医学会神经病学分会神经康复学组，中华医学会神经病学分会脑血管病学组，卫生部脑卒中筛查与防治工程委员会办公室，张通.中国脑卒中康复治疗指南（2011完全版）[J].中国康复理论与实践，2012，18（4）：301-318.
[7]	周娇娇，王巍巍，朱雪泉，等.PHQ-9 与HAMD-17 在抑郁症评估中的相关性[J].神经疾病与精神卫生，2019（2）：134-137.
[8]	巫嘉陵，安中平，王世民，等.脑卒中患者日常生活活动能力量表的信度与效度研究[J].中国现代神经疾病杂志，2009，9（5）：464-468.
[9]	官少兵，余映丽，黄益洪，等.艾司西酞普兰治疗老年急性缺血性脑卒中后抑郁疗效观察[J].中国实用神经疾病杂志，2017，20（4）：112-114.
[10]	Medeiros GC，Roy D，Kontos N，Beach SR.Post-stroke depression：A 2020 updated review[J].Gen Hosp Psychiatry.2020，66：70-80.
[11]	孟宪良，赵娜，张宁，等.卒中后抑郁的研究进展[J].中国实用神经疾病杂志，2019，22（18）：2082-2088.
[12]	Zhang Y，Wang C，Sun C，et al.Neural complexity in patients with poststroke depression：A resting EEG study[J].J Affect Disord，2015，188：310-8.
[13]	马式意，李柄佑，勾丽洁.脑卒中后抑郁发病机制及危险因素的研究进展[J].世界最新医学信息文摘（连续型电子期刊），2021，21（10）：120-121，124.
[14]	Li Y，Zhang X，Chen L，Yang B，et al.Cerebellar fastigial nucleus is involved in post-stroke depression through direct cerebellar-hypothalamic GABAergic and glutamatergic projections[J].Exp Ther Med，2019，18（4）：2885-2892.
[15]	Liang J，Yue Y，Jiang H，et al.Genetic variations in the p11/tPA/BDNF pathway are associated with post stroke depression[J].J Affect Disord，2018，226：313-325.
[17]	王雪，王倩，胡文卿，等.卒中后抑郁的中医证候及危险因素研究[J].西部中医药，2021，34（5）：107-111.
[19]	张鹏飞，廖丽君，邓祯，等.银杏叶提取物的药理作用及其临床应用研究进展[J].辽宁中医杂志，2017，44（2）：426-429.
[16]	河南省卒中学会卒中后心理与情感障碍分会，河南省医师协会精神科分会，河南省心理卫生协会.脑卒中后抑郁临床诊疗指南2020 版[J].临床心身疾病杂志，2020，26（3）：后插1-后插5，封3.
[18]	中国医师协会中西医结合医师分会，国家中医心血管病临床医学研究中心，中国中医药循证医学中心（心血管病项目组、脑病项目组）.口服银杏叶制剂临床应用中国专家共识（2020）[J].中国中西医结合杂志，2020，40（12）：1424-1429.